Cargando…
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
BACKGROUND: There is a paucity of data on community-based Clostridioides difficile infection (CDI) and how these compare with inpatient CDI. AIM: To compare data on the populations with CDI in hospitals vs the community across 12 European countries. METHODS: For this point-prevalence study (July–Nov...
Autores principales: | Viprey, Virginie F, Davis, Georgina L, Benson, Anthony D, Ewin, Duncan, Spittal, William, Vernon, Jon J, Rupnik, Maja, Banz, Alice, Allantaz, Florence, Cleuziat, Philippe, Wilcox, Mark H, Davies, Kerrie A, Novakova, Elena, Matussek, Andreas, Fitzpatrick, Fidelma, Simon, Anne, Macovei, Ioana, Barbut, Frederic, Ramirez, Elena Reigadas, Petinaki, Efi, Kuijper, Ed, Petrosillo, Nicola, Pituch, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248264/ https://www.ncbi.nlm.nih.gov/pubmed/35775426 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.26.2100704 |
Ejemplares similares
-
Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021) -
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019) -
JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013) -
Focusing stewardship to help tackle CDI
Publicado: (2020) -
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)